Lista de obras -

(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.

artículo científico publicado en 2014

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center

artículo científico publicado en 2015

A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism

artículo científico publicado en 2017

A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

artículo científico publicado en 2014

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

artículo científico publicado en 2016

Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival

artículo científico publicado en 2014

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.

artículo científico publicado en 2017

Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas cases

artículo científico publicado en 2013

Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma

scientific article published on 30 October 2018

Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy

artículo científico publicado en 2014

CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer

artículo científico publicado en 2013

Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China

artículo científico

Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China

artículo científico publicado en 2017

Critical role of oncogenic KRAS in pancreatic cancer (Review).

artículo científico publicado en 2016

Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis

scientific article published on 01 March 2019

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer

artículo científico publicado en 2015

Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma

artículo científico publicado en 2014

Energy sources identify metabolic phenotypes in pancreatic cancer.

artículo científico publicado en 2016

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

artículo científico publicado en 2014

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.

artículo científico publicado en 2016

Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties

artículo científico publicado en 2013

Human profilin 1 is a negative regulator of CTL mediated cell-killing and migration.

artículo científico publicado en 2017

Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors

artículo científico publicado en 2020

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

artículo científico publicado en 2013

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process.

artículo científico publicado en 2014

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer

artículo científico publicado en 2015

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer

artículo científico publicado en 2015

Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.

artículo científico publicado en 2015

Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection

artículo científico publicado en 2014

Molecular mechanism underlying lymphatic metastasis in pancreatic cancer

artículo científico publicado en 2014

Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

artículo científico publicado en 2016

New insights into perineural invasion of pancreatic cancer: More than pain

artículo científico publicado en 2016

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer

scientific article published on 09 August 2018

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.

artículo científico publicado en 2015

Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor.

artículo científico publicado en 2017

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping

artículo científico publicado en 2016

Pancreatic stump-closed pancreaticojejunostomy can be performed safely in normal soft pancreas cases.

artículo científico publicado en 2011

Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial

artículo científico publicado en 2015

Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.

artículo científico publicado en 2016

Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.

artículo científico publicado en 2016

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

artículo científico publicado en 2017

Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma

artículo científico publicado en 2015

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis

artículo científico publicado en 2014

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer

artículo científico publicado en 2016

Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery

artículo científico publicado en 2019

Reflections on depletion of tumor stroma in pancreatic cancer

scientific article published on 06 February 2019

Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma

artículo científico publicado en 2019

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

artículo científico publicado en 2016

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

artículo científico publicado en 2015

SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer

scientific article published on 02 June 2019

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

artículo científico publicado en 2016

Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.

artículo científico publicado en 2013

Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review

scientific article published on 28 March 2019

TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway

artículo científico publicado en 2020

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer

scientific article published on 08 July 2016

The Significance of Liquid Biopsy in Pancreatic Cancer

artículo científico publicado en 2018

The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)

scientific article published on 30 December 2015

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

artículo científico publicado en 2016

The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis

artículo científico publicado en 2023

The role of collagen in cancer: from bench to bedside

artículo científico publicado en 2019

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma

artículo científico publicado en 2019

Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma

artículo científico publicado en 2018

Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?

artículo científico publicado en 2016

Lista de obras de

(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center

A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism

A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.

Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas cases

Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma

Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy

CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer

Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China

Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China

Critical role of oncogenic KRAS in pancreatic cancer (Review).

Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer

Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma

Energy sources identify metabolic phenotypes in pancreatic cancer.

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.

Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties

Human profilin 1 is a negative regulator of CTL mediated cell-killing and migration.

Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process.

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer

Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.

Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection

Molecular mechanism underlying lymphatic metastasis in pancreatic cancer

Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

New insights into perineural invasion of pancreatic cancer: More than pain

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.

Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor.

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping

Pancreatic stump-closed pancreaticojejunostomy can be performed safely in normal soft pancreas cases.

Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial

Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.

Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer

Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery

Reflections on depletion of tumor stroma in pancreatic cancer

Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.

Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review

TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer

The Significance of Liquid Biopsy in Pancreatic Cancer

The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis

The role of collagen in cancer: from bench to bedside

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma

Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma

Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?